[1] 于世凤. 口腔组织病理学 [M]. 第6版. 北京: 人民卫生出版社, 2007: 287-288. [2] 温玉明, 代晓明, 王昌美, 等. 口腔颌面部恶性肿瘤6539例临床病理分析 [J]. 华西口腔医学杂志, 2001, 19(5): 296-299. [3] Grassot J, Gouy M, Perrière G, et al. Origin and molecular evolution of receptor tyrosine kinases with immunoglobulin-like domains [J]. Mol Biol Evol, 2006, 23(6): 1232-1241. [4] Luo LY, Hahn WC. Oncogenic signaling adaptor proteins [J]. J Genet Genomics, 2015, 42(10): 521-529. [5] 蒋毅, 马静, 韩代书. Tyro3受体酪氨酸激酶亚家族的研究进展 [J]. 中国组织化学与细胞化学杂志, 2005, 14(4): 466-469. [6] Di Marco E, Cutuli N, Guerra L, et al. Molecular cloning of trkE, a novel trk-related putative tyrosine kinase receptor isolated from normal human keratinocytes and widely expressed by normal human tissues [J]. J Biol Chem, 1993, 268(32): 24290-24295. [7] Alves F, Vogel W, Mossie K, at al. Distinct structural characteristics of discoidin I subfamily receptor tyrosine kinases and complementary expression in human cancer [J]. Oncogene, 1995, 10(3): 609-618. [8] Malaguarnera R, Nicolosi ML, Sacco A, et al. Novel cross talk between IGF-IR and DDR1 regulates IGF-IR trafficking, signaling and biological responses [J]. Oncotarget, 2015, 6(18): 16084-16105. [9] Faraci E, Eck M, Gerstmayer B, et al. An extracellular matrix-specific microarray allowed the identification of target genes downstream of discoidin domain receptors [J]. Matrix Biol, 2003, 22(4): 373-381. [10] Carbone A, Gloghini A. Activated DDR1 increases RS cell survival [J]. Blood, 2013, 122(26): 4152-4154. [11] Reel B, Korkmaz CG, Arun MZ, et al. The regulation of matrix metalloproteinase expression and the role of discoidin domain receptor 1/2 signalling in zoledronate-treated PC3 cells [J]. J Cancer, 2015, 6(10): 1020-1029. [12] Dejmek J, Leandersson K, Manjer J, et al. Expression and signaling activity of Wnt-5a/discoidin domain receptor-1 and Syk plays distinct but decisive roles in breast cancer patient survival [J]. Clin Cancer Res, 2005, 11(2 Pt 1): 520-528. [13] Ongusaha PP, Kim JI, Fang L, et al. p53 induction and activation of DDR1 kinase counteract p53-mediated apoptosis and influence p53 regulation through a positive feedback loop [J]. EMBO J, 2003, 22(6): 1289-1301. [14] Quan J, Yahata T, Adachi S, et al. Identification of receptor tyrosine kinase, discoidin domain receptor 1 (DDR1), as a potential biomarker for serous ovarian cancer [J]. Int J Mol Sci, 2011, 12(2): 971-982. [15] Shimada K, Nakamura M, Ishida E, et a1. Prostate cancer antigen-1 contributes to cell survival and invasion though discoidin receptor 1 in human prostate cancer [J]. Cancer Sci, 2008, 99(1): 39-45. [16] 黄海涛, 刘华蔚, 王如, 等. 412例腮腺恶性肿瘤回顾分析 [J]. 上海口腔医学, 2014, 23(3): 340-345. [17] 周全, 刘洪刚, 金玉兰, 等. 颈部淋巴结黏液表皮样癌 [J]. 临床与实验病理学杂志, 2009, 25(1): 41-45. [18] 吴红珍, 江新青, 魏新华, 等. 腮腺黏液表皮样癌的CT诊断及鉴别诊断(附3例报告) [J]. 中国CT和MRI杂志, 2015, 13(2): 10-11. [19] 张惠, 向素芳, 邓立强, 等. 涎腺黏液表皮样癌的超声表现及病理学基础 [J]. 四川医学, 2014, 35(9): 1235-1236. [20] 史璐, 陈新明, 陈智, 等. 小涎腺黏液表皮样癌临床病理及血管生成的研究 [J]. 口腔医学研究, 2010, 26(4): 524-528. [21] 赵尔杨, 王姗, 施磊, 等. 口腔黏膜癌中HIF-1a、VEGF表达与血管生成关系的研究 [J]. 口腔医学研究, 2009, 25(5): 545-547. [22] Johnson JD, Edman JC, Rutter WJ. A receptor tyrosine kinase found in breast carcinoma cells has an extracellular discoidin I-like domain [J]. Proc Natl Acad Sci USA, 1993, 90(12):5677-5681. [23] Ferri N, Carragher NO, Raines EW. Role of discoidin domain receptors 1 and 2 in human smooth muscle cell-mediated collagen remodeling: potential implications in atherosclerosis and lymphangioleiomyomatosis [J]. Am J Pathol, 2004, 164(5): 1575-1585. [24] Shyu KG, Chao YM, Wang BW, et al. Regulation of discoidin domain receptor 2 by cyclic mechanical stretch in cultured rat vascular smooth muscle cells [J]. Hypertension, 2005, 46(3): 614-621. [25] Lee R, Eidman KE, Kren SM, et al. Localization of discoidin domain receptors in rat kidney [J]. Nephron Exp Nephrol, 2004, 97(2): e62-70. [26] Matsuyama W, Watanabe M, Shirahama Y, et al. Activation of discoidin domain receptor 1 on CD14-positive bronchoalveolar lavage fluid cells induces chemokine production in idiopathic pulmonary fibrosis [J]. J Immunol, 2005, 174(10): 6490-6498. [27] Heinzelmann-Schwarz VA, Gardiner-Garden M, Henshall SM, et al. Overexpression of the cell adhesion molecules DDR1, Claudin 3, and Ep-CAM in metaplastic ovarian epithelium and ovarian cancer [J]. Clin Cancer Res, 2014, 10(13): 4427-4436. [28] Ford CE, Lau SK, Zhu CQ, et al. Expression and mutation analysis of the discoidin domain receptors 1 and 2 in non-small cell lung carcinoma [J]. Br J Cancer, 2007, 96(5): 808-814. [29] Yang J, Liu J, Zhong M, et al. Discoidin domain receptors: a promoter of the aggressive behavior of ameloblastomas [J]. IUBMB Life, 2014, 66(4): 292-299. [30] 李超, 向小勇, 陈力, 等. 盘状结构域受体1在食管鳞癌组织中的表达 [J]. 重庆医科大学报, 2008, 33(9): 1115-1117. [31] Neuhaus B, Bühren S, Böck B, et al. Migration inhibition of mammary epithelial cells by Syk is blocked in the presence of DDR1 receptors [J]. Cell Mol Life Sci, 2011, 68(22): 3757-3770. [32] Miao L, Zhu S, Wang Y, et a1. Discoidin domain receptor 1 is associated with poor prognosis of non-small cell lung cancer and promotes cell invasion via epithelial-to-mesenchymal transition [J]. Med Oncol, 2013, 30(3): 626-634. [33] Valencia K, Ormazábal C, Zandueta C, et al. Inhibition of collagen receptor discoidin domain receptor-1(DDR1) reduces cell survival, homing, and colonization in lung cancer bone metastasis [J]. Clin Cancer Res, 2012, 18(4):969-980. |